Articles

Reducing waiting times at Norwegian hospitals is one of the Minister of Health’s highest priorities, as emphasized by Jan Christian Vestre in the Health Speech 2025. Now, Oslo Economics will assist the Ministry of Health and Care Services in eliminating time-wasters in Norwegian hospitals.

The district court’s ruling aligns with Oslo Economics’ analyses and conclusions. The mobile operators seeking compensation for damages did not have the necessary knowledge to document Telenor’s violation of the Competition Act.

Eivind Jørgensen, one of Norway’s most experienced health economists, will take on the role of Associate Partner at Oslo Economics.

In a case between Oslo municipality and two commercial providers of nursing homes (Norlandia and Stendi), Borgarting Court of Appeals has decided that Oslo municipality’s exclusion of commercial providers from a public procurement of nursing home services was unlawful.

Our recently published study on adherence to lipid-lowering drugs was featured in a newspaper article in Dagens Medisin. Our study tracks all patients in Norway who initiated treatment with proprotein convertase subtilisin/kexin type 9 monoclonal antibodies (PCSK9 mAbs) from 2015 to 2023.

On November 27, Oslo Economics and Bristol Myers Squibb are hosting a breakfast meeting on the healthcare system’s structure and its ability to prioritize in today’s rapidly evolving technological landscape.
Join us to hear presentations from a range of engaging speakers and participate in the discussion.

Oslo Economics has received research funding from the Norwegian Competition Authority for the implementation of the project “Cooperation on green development projects – possible effects and gains”.

Last week, a case of importance for state aid law and competition economics was heard in the Supreme Court in Norway.

In collaboration with REMEDY-Centre for Treatment of Rheumatic and Musculoskeletal Diseases at Diakonhjemmet hospital, we have published an article investigating stroke management in atrial fibrillation patients with rheumatoid arthritis. The investigation relies on Norwegian registry data from hospitals and pharmacies.

Oslo Economics’ estimates that the number of assignments for interpreting services carried out in spoken languages increased with approximately 40 percent from 2022 to 2023. The equivalent increase in assignments for deaf, hard of hearing and deafblind was around 4 percent

Oslo Economics remains the economics consultancy with most competition experts recognized by Who’s Who Legal in the Nordics. 

This week, Oslo Economics participated in a research workshop on international experiences with primary health care teams, together with researchers from Norway, France, Germany, and Canada.